Related Experiment Video
Updated: May 12, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
USA300 methicillin-resistant Staphylococcus aureus in Norway
Aina E Fossum Moen1, Tone Møller Tannaes, Truls Michael Leegaard
1Department of Clinical Molecular Biology and Laboratory Sciences (EpiGen), Division of Medicine, Akershus University Hospital and University of Oslo, Lørenskog, Norway.
Community-associated methicillin-resistant Staphylococcus aureus (MRSA) USA300 has been detected in Norway since 2003. This adaptable strain shows increasing incidence, primarily in the community but also in healthcare settings.
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) USA300 is a globally disseminated clone.
- Understanding the establishment and prevalence of specific MRSA strains is crucial for public health.
Purpose of the Study:
- To investigate the presence and endemic establishment of the USA300 MRSA strain in Norway.
- To track the incidence of USA300 MRSA in relation to overall MRSA trends.
Main Methods:
- Utilized strain typing techniques including spa-, SCCmec-, and dru-typing.
- Employed pulsed-field gel electrophoresis (PFGE) and molecular marker detection (lukS/F-PV, arcA).
Main Results:
- USA300 MRSA has been present in the studied Norwegian region since 2003.
- The incidence of USA300 MRSA has risen in parallel with the total MRSA incidence.
- Isolates were predominantly found in the community, with some detected in healthcare settings.
Conclusions:
- The USA300 MRSA clone is established and increasing in Norway.
- Surveillance for CA-MRSA strains is important in both community and healthcare environments.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
